# Radboudumc Centre for Oncology

Source: https://onco.cc/institutions/radboudumc/  
OnCo record `radboudumc` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The university hospital of Nijmegen, a leading Dutch centre for prostate imaging, dendritic cell vaccines and tumour immunology, currently in OECI accreditation.

## Summary

Radboud University Medical Center is the academic hospital of Radboud University and a tertiary cancer centre for the east of the Netherlands. Its Centre for Oncology integrates medical oncology, radiotherapy, haematology, surgical oncology and urology, and its research is internationally recognised in prostate MRI and PSMA imaging, dendritic cell vaccination and tumour immunology (Radboud Institute for Molecular Life Sciences), hereditary cancer, and hepatobiliary and pancreatic surgery. Radboudumc is listed by the Organisation of European Cancer Institutes as in accreditation.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: Radboud University Medical Center
- Tags: oeci-in-accreditation
- City: Nijmegen, NL
- Type: hospital
- Website: https://www.radboudumc.nl

## Sources

- Official website: https://www.radboudumc.nl

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [PSMA PET](https://onco.cc/technologies/psma-pet/)
- institutions: [Organisation of European Cancer Institutes](https://onco.cc/institutions/oeci/), [Rijnstate](https://onco.cc/institutions/rijnstate-arnhem/)
- people: [Bertine Lahuis](https://onco.cc/people/bertine-lahuis/), [Haiko Bloemendal](https://onco.cc/people/haiko-bloemendal/)
- key papers: [Deficient mismatch repair system in patients with sporadic advanced colorectal cancer](https://onco.cc/key-papers/paper-koopman-deficient-mismatch-repair-advanced-colorectal-bjc-2009/), [Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1](https://onco.cc/key-papers/paper-ligtenberg-epcam-deletion-msh2-silencing-nat-genet-2009/), [Mismatch repair status and BRAF mutation status in metastatic colorectal cancer: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies](https://onco.cc/key-papers/paper-venderbosch-mmr-braf-metastatic-colorectal-pooled-ccr-2014/), [Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia](https://onco.cc/key-papers/paper-crockett-nagtegaal-serrated-neoplasia-gastroenterology-2019/)

---
JSON: https://onco.cc/api/v1/entities/radboudumc.json